Combination drug-hormone therapy of the advanced stages of breast carcinoma
Fazio, M.; Cavallero, P.; Rattalino, G.; Sartoris, S.; Vergnano, F.
Minerva Ginecologica 28(7-8): 623-629
1976
ISSN/ISBN: 0026-4784 PMID: 1037112 Document Number: 100467
Document emailed within 1 workday
Related Documents
Petru, E.; Beck, K.; Schünemann, H.; Schmähl, D. 1991: The significance of hormone receptor content in primary tumors for cytostatic therapy of advanced breast carcinoma Wiener Medizinische Wochenschrift 141(7): 133-135Berndt, G.; Eckel, H.; Notter, G.; St Stender, H. 1971: Effect of estrogen-gestagen combination therapy in advanced breast carcinoma with special reference to pulmonary metastases Strahlentherapie 141(5): 540-548
Soma, I.; Hasuike, Y.; Hayashi, N.; Fukuchi, N.; Izawa, H.; Yoshida, T.; Ebisui, C.; Sakita, I.; Fujimoto, T.; Koshino, T.; Izumiyama, K. 2004: A case report--Efficacy of combination therapy to unresectable advanced gall bladder carcinoma--palliative operation, hepatic arterial infusion therapy, and radiation therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(11): 1903-1905
Studer, U.E. 1995: Advanced prostatic carcinoma--which hormone therapy when? Der Urologe. Ausg. a 34(5): 361-366
Izumi, M.; Iino, Y.; Yokoe, T.; Inoue, T.; Yamada, T.; Kobayashi, I.; Andoh, T.; Yokota, T.; Iijima, T.; Morishita, Y. 1994: Advanced breast cancer with remarkable response to the combination therapy of mitoxantrone (MIT) and medroxyprogesteron acetate (MPA) after failure of anthracycline therapy: a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(2): 265-268
Manziuk, L.V.; Komov, D.V.; Khaĭlenko, V.A.; Artamonova, E.V.; Mikhina, Z.P.; Ermilova, V.D.; Abashin, S.I. 2001: Combination therapy of patients with locally advanced breast cancer Voprosy Onkologii 47(6): 740-743
Geyer, G. 1980: New results in the field of endocrinology with relevance for medical practice. Hyperprolactemia, endocrine adenomatoses, paraneoplastic hormone secretion and hormone therapy of breast carcinoma Wiener Medizinische Wochenschrift 130(15-16): 501-509
Hernádi, Z.; Juhász, B.; Póka, R.; Mahunka, I.; Lampé, L. 1987: Analysis of the effectiveness and adverse effects of the drug combinations CAP and CEP in the therapy of patients in the advanced stages of ovarian cancer Orvosi Hetilap 128(47): 2457-2461
Iemwananonthachai, N.; Pattaranutaporn, P.; Chansilpa, Y.; Sukkasem, M. 2003: Hyperthermia in combination with radiation therapy for treatment of advanced inoperable breast cancer Journal of the Medical Association of Thailand 86(8): 715-721
La Vecchia, C.; Franceschi, S.; Gritti, P.; Valente, I. 1980: Hormone therapy in advanced forms of carcinoma of the endometrium: analysis and prospects Annali di Ostetricia Ginecologia Medicina Perinatale 101(3): 181-186
Santen, R.J.; Pinkerton, J.; McCartney, C.; Petroni, G.R. 2001: Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy Journal of Clinical Endocrinology and Metabolism 86(1): 16-23
Iglódi, F. 1989: Endocrine therapy monitored by hormone cytological examination in advanced female breast cancer Therapia Hungarica 37(4): 205-208
Albeshan, S.M.; Hossain, S.Z.; Mackey, M.G.; Brennan, P.C. 2020: Can Breast Self-examination and Clinical Breast Examination Along with Increasing Breast Awareness Facilitate Earlier Detection of Breast Cancer in Populations with Advanced Stages at Diagnosis? Clinical Breast Cancer 20(3): 194-200
Dank, M.; Zergenyi, E.; Domotori, Z.S.; Lahm, E.; Kulka, J. 2003: Primary systemic therapy (PST) of locally advanced breast cancer using Doxorubicin/Docetaxel combination Anticancer Research 23(3c): 2879-2880
Sonoo, H.; Senoo, T.; Nishiki, M.; Morimoto, T.; Takashima, S. 1996: Effectiveness of combination hormonal therapies in advanced or recurrent breast cancer--a randomized trial of tamoxifen (TAM), medroxyprogesterone acetate (MPA), their simultaneous combination, and an alternating sequential combination of TAM plus MPA Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(4): 447-454
Schneider, G. 1993: Adjuvant hormone therapy in breast carcinoma Deutsche Medizinische Wochenschrift 118(25): 961-962
Novoa Vargas, A.; Font López, K.C.; Amador, D.D. 2011: Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer Ginecologia y Obstetricia de Mexico 79(9): 553-557
Foggi, P.; Amodio, A. 2003: Molecular therapy of breast carcinoma in the advanced phase Tumori 89(4 Suppl): 189-191
Lehnert, M.; Biffl, G.; Wascher, H.; Jordis-Lohausen, K.; Wählby, S. 1986: A preliminary analysis of combination therapy with vincristine, adriamycin, and prednimustine (VAP) in advanced breast cancer: a phase Ii study Seminars in Oncology 13(1 Suppl 1: 32-34
Nomura, Y.; Tashiro, H.; Hisamatsu, K.; Toi, M. 1988: Effects of high-dose medroxyprogesterone acetate in advanced breast cancer, with special reference to prior endocrine therapy and hormone receptors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(3): 513-518